Search results
Immunotherapy drug may help 'cure' advanced colorectal cancer without surgery
MedicalNewsToday via AOL· 5 hours agoGiving the immunotherapy drug pembrolizumab before surgery instead of chemotherapy may help improve...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoThe results showed a 12-month overall survival (“...
CG Oncology reports promising bladder cancer trial results By Investing.com
Investing.com· 2 hours agoThe study, focusing on patients with BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC),...
New combination therapy shows promise for bladder cancer patients unresponsive to standard treatment
Medical Xpress· 3 hours agoThe trial included patients with BCG-unresponsive carcinoma in situ of the bladder, a condition that...
Drug already available on NHS could help cure deadly form of bowel cancer
Daily Telegraph· 4 days agoPembrolizumab works by blocking the action of a molecule called PD-1 that hides the cancer from the...
TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024...
Clearfield Progress· 5 days ago(Kosdaq: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable diseases, announced interim results ...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
The Woonsocket Call· 5 days agoOlomorasib is an investigational, oral, potent, and highly selective second-generation inhibitor of the KRAS G12C protein.
A Deeper Look at Anti-PD-1/PD-L1 Checkpoint Inhibitors for Cancer
Forbes· 7 days agoIn a previous story, I described pembrolizumab, a PD-1 targeting checkpoint inhibitor, in some...
Breakthrough bowel cancer drug 'could triple survival chances' for patients
Daily Express· 4 days agoA blockbuster drug could triple survival chances for some bowel cancer patients by “melting away”...
An mRNA Melanoma Vaccine Shows Promise
Time via Yahoo News· 6 days agoIn the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint inhibitor ...
